CJC-1295

Also known as: DAC-GRF, CJC-1295 DAC, Mod GRF 1-29

Plausible Theory

Classification

Peptide

Regulatory Status

not-established

Sources

Review

n/a

Overview

CJC-1295 is a synthetic analog of GHRH 1-29 that stimulates pituitary GH release; a DAC form is designed for longer exposure. DAC vs non-DAC (Mod GRF 1-29) naming confusion is common.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

GH-IGF-1 axispituitary somatotroph signalingGHRH receptor agonismGH secretion stimulationGHRH receptor

Interactions & cautions

Flagged in source data

tesamorelin or other GH secretagogues

Drug interactions

other GH secretagogues or GHRH analogs — Additive GH/IGF-I effects and overlapping safety monitoring burden are plausible. (review)

These are observational flags for review, not individualized instructions.

Sources

https://www.fda.gov/media/183819/download (opens in a new tab)
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks (opens in a new tab)
https://pubmed.ncbi.nlm.nih.gov/16352683/ (opens in a new tab)

Educational reference only — not medical advice.